News
![Pharnext appoints Valérie Worrall as Chief Financial Officer](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Pharnext appoints Valérie Worrall as Chief Financial Officer
Pharnext appoints Valérie Worrall as Chief Financial Officer
![ALTHEORA: Strong acceleration of activity in 2021: +15% - 2022 Orders: +16%](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
ALTHEORA: Strong acceleration of activity in 2021: +15% - 2022 Orders: +16%
ALTHEORA: Strong acceleration of activity in 2021: +15% - 2022 Orders: +16%
![ALTHEORA: 2022 financial calendar](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
ALTHEORA: 2022 financial calendar
ALTHEORA: 2022 financial calendar
![ROCTOOL: Decathlon, with its design & industrialization teams, launches its first production of 'Eco-Molded' helmets with Roctool technology](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
ROCTOOL: Decathlon, with its design & industrialization teams, launches its first production of 'Eco-Molded' helmets with Roctool technology
ROCTOOL: Decathlon, with its design & industrialization teams, launches its first production of 'Eco-Molded' helmets with Roctool technology
![Experienced Pharmaceutical Industry Executive Dr. Elisabeth Svanberg Appointed as Chairman of Pharnext Board of Directors](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Experienced Pharmaceutical Industry Executive Dr. Elisabeth Svanberg Appointed as Chairman of Pharnext Board of Directors
Experienced Pharmaceutical Industry Executive Dr. Elisabeth Svanberg Appointed as Chairman of Pharnext Board of Directors
![Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022
Pharnext and Global Tech Opportunities 13 Agree to Stop Convertible Bond Program from End of May 2022
![SPAC: Mr. Jean-François OTT appointed CEO of SPAC](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
SPAC: Mr. Jean-François OTT appointed CEO of SPAC
SPAC: Mr. Jean-François OTT appointed CEO of SPAC
![BILENDI: Bilendi announces the completion of the the acquisition of the respondi group](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
BILENDI: Bilendi announces the completion of the the acquisition of the respondi group
![Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development
Pharnext appoints Dr. Burkhard Blank as new Chief Medical Officer and Head of Research & Development
![BILENDI: Bilendi acquires the respondi Group, a European player in data collection for market research](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
BILENDI: Bilendi acquires the respondi Group, a European player in data collection for market research
BILENDI: Bilendi acquires the respondi Group, a European player in data collection for market research